TELA Bio News

Express News | Tela Bio, board of directors increases the number of members to seven.

BreakingsJun 6 15:18

Express News | TELA Bio Inc - Board Increased Size of Board to Seven Members

BreakingsJun 6 15:17

Lake Street Maintains TELA Bio(TELA.US) With Buy Rating, Maintains Target Price $14

Lake Street analyst Frank Takkinen maintains $TELA Bio(TELA.US)$ with a buy rating, and maintains the target price at $14.According to TipRanks data, the analyst has a success rate of 34.2% and a tota

Futu NewsJun 6 08:31

Express News | TELA Bio Appoints Jeffrey Blizard to Its Board of Directors

BreakingsJun 4 15:05

Analysts Are Bullish on Top Healthcare Stocks: TELA Bio (TELA), Rezolute (RZLT)

TipRanksMay 22 05:50

Analysts Offer Insights on Healthcare Companies: Evogene (EVGN), TELA Bio (TELA) and InfuSystem Holdings, Inc. (INFU)

TipRanksMay 21 08:01

Press Release: TELA Bio Appoints Greg Firestone as Chief Commercial Officer

TELA Bio Appoints Greg Firestone as Chief Commercial Officer MALVERN, Pa., May 20, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on pro

Dow JonesMay 20 15:03

TELA Bio, Inc. (NASDAQ:TELA) Q1 2024 Earnings Call Transcript

Yahoo FinanceMay 13 10:01

TELA Bio First Quarter 2024 Earnings: US$0.23 Loss per Share (Vs US$0.63 Loss in 1Q 2023)

Yahoo FinanceMay 11 09:53

TELA Bio | 10-Q: Quarterly report

SEC announcementMay 10 15:17 · Announcements

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., May 10, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ:TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions,

GlobeNewswireMay 10 15:05

TELA Bio Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Revenue Results and Raised Its FY24 Revenue Guidance.

TELA Bio Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Revenue Results and Raised Its FY24 Revenue Guidance.

BenzingaMay 10 10:35

TELA Bio Price Target Cut to $10.00/Share From $12.00 by Piper Sandler

TELA Bio Price Target Cut to $10.00/Share From $12.00 by Piper Sandler

Dow JonesMay 10 08:36

Piper Sandler Reiterates Overweight on TELA Bio, Lowers Price Target to $10

Piper Sandler analyst Matt O'Brien reiterates TELA Bio with a Overweight and lowers the price target from $12 to $10.

Analyst UpgradesMay 10 08:26

TELA Bio Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/10/2024 97.63% Piper Sandler $12 → $10 Reiterates Overweight → Overweight 03/22/2024 196.44% JMP Securi

BenzingaMay 10 08:25

TELA Bio's Robust Growth and Promising Outlook Merit Bullish Stance

TipRanksMay 10 07:17

TELA Bio (TELA) Gets a Buy From Piper Sandler

TipRanksMay 10 07:04

TELA Bio Increases FY24 Revenue Guidance From $74M-$76M To $74.5M-$76.5M, Est $74.94M

TELA Bio Increases FY24 Revenue Guidance From $74M-$76M To $74.5M-$76.5M, Est $74.94M

BenzingaMay 9 16:33

TELA Bio Reveals Strategic Direction in Updated Investor Deck

TipRanksMay 9 15:33

12 Health Care Stocks Moving In Thursday's After-Market Session

GainersSensus Healthcare (NASDAQ:SRTS) shares increased by 33.3% to $5.08 during Thursday's after-market session. The market value of their outstanding shares is at $83.2 million. As per the news, the

BenzingaMay 9 15:31